Alnylam Pharmaceuticals (ALNY) P/E US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| P/E | ? | -23.6 | 0.00 | 0.00 | -108.0 | 166.0 | 64.0 | |
| Changes by years, y/y, % | +35% | -100% | -254% | |||||
Alnylam Pharmaceuticals. P/E
Alnylam Pharmaceuticals. P/E, changes, %
Alnylam Pharmaceuticals (ALNY) P/E US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| P/E | ? | -129.8 | -132.5 | 1 376 | 167.6 | 76.2 | 64.0 | |
| Changes by years, y/y, % | -1 393% | -254% | -159% | |||||
| Changes by quarters, q/q, % | +19% | +2% | -1 138% | -88% | -55% | |||